Findlay Park Partners’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$155M	Sell	616,766 -50,160	-8%	-$12.5M	2.15%	18
2025 Q4	$183M	Sell	666,926 -135,180	-17%	-$37M	2.34%	16
2025 Q3	$210M	Sell	802,106 -14,500	-2%	-$3.52M	2.21%	16
2025 Q2	$179M	Sell	816,606 -29,600	-3%	-$6.33M	1.84%	22
2025 Q1	$189M	Buy	846,206 +11,500	+1%	+$3.17M	1.95%	21
2024 Q4	$273M	Buy	834,706 +7,000	+0.8%	+$2.2M	2.72%	9
2024 Q3	$248M	Buy	827,706 +85,800	+12%	+$26.3M	2.34%	11
2024 Q2	$244M	Buy	741,906 +144,800	+24%	+$51.2M	2.3%	19
2024 Q1	$236M	Buy	597,106 +139,800	+31%	+$51.7M	2.17%	18
2023 Q4	$161M	Buy	457,306 +180,415	+65%	+$63.8M	1.58%	27
2023 Q3	$104M	Sell	276,891 -2,611	-0.9%	-$1.01M	1.12%	40
2023 Q2	$107M	Sell	279,502 -17,538	-6%	-$6.27M	1.1%	43
2023 Q1	$103M	Buy	297,040 +125,138	+73%	+$36.6M	1.09%	42
2022 Q4	$40.5M	Buy	+171,902	New	+$40.7M	0.44%	46